Trupanion, Inc. (NASDAQ:TRUP) Shares Purchased by Principal Financial Group Inc.

Principal Financial Group Inc. raised its stake in Trupanion, Inc. (NASDAQ:TRUP) by 3.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 163,188 shares of the financial services provider’s stock after purchasing an additional 5,412 shares during the period. Principal Financial Group Inc. owned 0.39% of Trupanion worth $7,866,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Fernwood Investment Management LLC grew its stake in Trupanion by 33.3% during the 3rd quarter. Fernwood Investment Management LLC now owns 20,000 shares of the financial services provider’s stock worth $840,000 after buying an additional 5,000 shares during the last quarter. Hanseatic Management Services Inc. purchased a new position in shares of Trupanion during the third quarter worth approximately $538,000. Sigma Planning Corp acquired a new position in shares of Trupanion in the 3rd quarter valued at $336,000. Entropy Technologies LP purchased a new stake in Trupanion in the 3rd quarter valued at $202,000. Finally, GSA Capital Partners LLP boosted its stake in Trupanion by 51.3% during the 3rd quarter. GSA Capital Partners LLP now owns 10,487 shares of the financial services provider’s stock worth $440,000 after purchasing an additional 3,554 shares during the period.

Trupanion Stock Up 2.8 %

Shares of NASDAQ:TRUP opened at $34.54 on Friday. The company has a market cap of $1.46 billion, a price-to-earnings ratio of -150.17, a PEG ratio of 6.02 and a beta of 1.60. Trupanion, Inc. has a fifty-two week low of $19.69 and a fifty-two week high of $57.90. The firm’s 50-day simple moving average is $45.87 and its 200-day simple moving average is $47.84. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). The business had revenue of $337.31 million during the quarter, compared to analysts’ expectations of $335.41 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. As a group, equities research analysts predict that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Insider Buying and Selling

In other Trupanion news, CFO Fawwad Qureshi sold 1,373 shares of the firm’s stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $34.22, for a total value of $46,984.06. Following the completion of the sale, the chief financial officer now owns 2,416 shares of the company’s stock, valued at approximately $82,675.52. This trade represents a 36.24 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 5.50% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

TRUP has been the subject of a number of research reports. Stifel Nicolaus reduced their target price on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a report on Thursday, February 20th. Piper Sandler reduced their price objective on Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a research note on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $46.60.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.